199 related articles for article (PubMed ID: 32248706)
21. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
22. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
[TBL] [Abstract][Full Text] [Related]
23. Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility.
Cameli P; Caffarelli C; Refini RM; Bergantini L; d'Alessandro M; Armati M; Tomai Pitinca MD; Sestini P; Gonnelli S; Bargagli E
Front Med (Lausanne); 2020; 7():568020. PubMed ID: 33195314
[No Abstract] [Full Text] [Related]
24. Is there an association between serum soluble interleukin-2 receptor levels and syndrome severity in persistent Complex Regional Pain Syndrome?
Mangnus TJP; Bharwani KD; Dik WA; Baart SJ; Dirckx M; Huygen FJPM
Pain Med; 2023 Nov; 24(11):1234-1243. PubMed ID: 37335874
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group.
Naveau S; Balian A; Degos F; Daurat V; Chevret S; Gayno S; Bastie A; Riachi G; Bartolomei-Portal I; Barange K; Moussalli J; Bailly F; Chaumet-Riffaud P; Emilie D
J Hepatol; 1999 Oct; 31(4):612-7. PubMed ID: 10551383
[TBL] [Abstract][Full Text] [Related]
27. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
[TBL] [Abstract][Full Text] [Related]
28. Biological role of the soluble interleukin-2 receptor in sarcoidosis.
Vanmaris RMM; Rijkers GT
Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(2):122-129. PubMed ID: 32476833
[TBL] [Abstract][Full Text] [Related]
29. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
30. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.
Ishihara M; Meguro A; Ishido M; Takeuchi M; Shibuya E; Mizuki N
Clin Ophthalmol; 2020; 14():2311-2317. PubMed ID: 32848359
[TBL] [Abstract][Full Text] [Related]
32. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma.
Kita T; Watanabe S; Yano F; Hayashi K; Yamamoto M; Iwasaki Y; Kosuda S
Ann Nucl Med; 2007 Nov; 21(9):499-503. PubMed ID: 18030581
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases.
Dik WA; Heron M
Neth J Med; 2020 Sep; 78(5):220-231. PubMed ID: 33093245
[TBL] [Abstract][Full Text] [Related]
35. The clinical value of serum soluble interleukin-2 receptor in pulmonary sarcoidosis.
Ogata-Suetsugu S; Hamada N; Takayama K; Tsubouchi K; Arimura-Omori M; Nakanishi Y
Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(1):41-47. PubMed ID: 32476821
[No Abstract] [Full Text] [Related]
36. Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases.
Bergantini L; d'Alessandro M; Vietri L; Rana GD; Cameli P; Acerra S; Sestini P; Bargagli E
Immunol Res; 2020 Dec; 68(6):414-421. PubMed ID: 33089426
[TBL] [Abstract][Full Text] [Related]
37. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.
Bargagli E; Bianchi N; Margollicci M; Olivieri C; Luddi A; Coviello G; Grosso S; Rottoli P
Scand J Clin Lab Invest; 2008; 68(6):479-83. PubMed ID: 18609101
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
[TBL] [Abstract][Full Text] [Related]
39. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.
Sawayama Y; Hayashi J; Kawakami Y; Furusyo N; Ariyama I; Kishihara Y; Ueno K; Kashiwagi S
Dig Dis Sci; 1999 Jan; 44(1):163-9. PubMed ID: 9952238
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker?
D'Alessandro M; Bergantini L; Carleo A; Cameli P; Perrone A; Fossi A; Sestini P; Bargagli E
Minerva Med; 2022 Jun; 113(3):526-531. PubMed ID: 32407050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
